BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 22057501)

  • 1. Liposomal nanostructures for photosensitizer delivery.
    Jin CS; Zheng G
    Lasers Surg Med; 2011 Sep; 43(7):734-48. PubMed ID: 22057501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoparticles as vehicles for delivery of photodynamic therapy agents.
    Bechet D; Couleaud P; Frochot C; Viriot ML; Guillemin F; Barberi-Heyob M
    Trends Biotechnol; 2008 Nov; 26(11):612-21. PubMed ID: 18804298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles in photodynamic therapy: an emerging paradigm.
    Chatterjee DK; Fong LS; Zhang Y
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1627-37. PubMed ID: 18930086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomal delivery of photosensitising agents.
    Chen B; Pogue BW; Hasan T
    Expert Opin Drug Deliv; 2005 May; 2(3):477-87. PubMed ID: 16296769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The liposomal formulation of doxorubicin.
    Abraham SA; Waterhouse DN; Mayer LD; Cullis PR; Madden TD; Bally MB
    Methods Enzymol; 2005; 391():71-97. PubMed ID: 15721375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal photosensitizers: potential platforms for anticancer photodynamic therapy.
    Muehlmann LA; Joanitti GA; Silva JR; Longo JP; Azevedo RB
    Braz J Med Biol Res; 2011 Aug; 44(8):729-37. PubMed ID: 21969965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes for photodynamic therapy.
    Derycke AS; de Witte PA
    Adv Drug Deliv Rev; 2004 Jan; 56(1):17-30. PubMed ID: 14706443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New trends and safety of photodynamic therapy].
    Osmałek T; Gośliński T; Mielcarek J; Osmałek E
    Przegl Lek; 2012; 69(11):1205-8. PubMed ID: 23646448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting-triggered porphysome nanostructure disruption for activatable photodynamic therapy.
    Jin CS; Cui L; Wang F; Chen J; Zheng G
    Adv Healthc Mater; 2014 Aug; 3(8):1240-9. PubMed ID: 24464930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of liposomal porphyrinoid photosensitizers.
    Skupin-Mrugalska P; Piskorz J; Goslinski T; Mielcarek J; Konopka K; Düzgüneş N
    Drug Discov Today; 2013 Aug; 18(15-16):776-84. PubMed ID: 23591149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted photodynamic therapy--a promising strategy of tumor treatment.
    Bugaj AM
    Photochem Photobiol Sci; 2011 Jul; 10(7):1097-109. PubMed ID: 21547329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Delivery of photosensitizers for photodynamic therapy].
    Park S
    Korean J Gastroenterol; 2007 May; 49(5):300-13. PubMed ID: 17525518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration.
    Decker C; Schubert H; May S; Fahr A
    J Control Release; 2013 Mar; 166(3):277-85. PubMed ID: 23313962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liposomes in topical photodynamic therapy.
    Dragicevic-Curic N; Fahr A
    Expert Opin Drug Deliv; 2012 Aug; 9(8):1015-32. PubMed ID: 22731896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photosensitizer delivery for photodynamic therapy of choroidal neovascularization.
    Renno RZ; Miller JW
    Adv Drug Deliv Rev; 2001 Oct; 52(1):63-78. PubMed ID: 11672876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative characterization of the cellular uptake and photodynamic efficiency of Foscan® and Fospeg in a human prostate cancer cell line.
    Petri A; Yova D; Alexandratou E; Kyriazi M; Rallis M
    Photodiagnosis Photodyn Ther; 2012 Dec; 9(4):344-54. PubMed ID: 23200016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposomal formulations of photosensitizers.
    Ghosh S; Carter KA; Lovell JF
    Biomaterials; 2019 Oct; 218():119341. PubMed ID: 31336279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic efficacy of photosensitizers under an attenuated light dose via lipid nano-carrier-mediated nuclear targeting.
    Ling D; Bae BC; Park W; Na K
    Biomaterials; 2012 Jul; 33(21):5478-86. PubMed ID: 22560197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine.
    Sutoris K; Vetvicka D; Horak L; Benes J; Nekvasil M; Jezek P; Zadinova M; Pouckova P
    Anticancer Res; 2012 Sep; 32(9):3769-74. PubMed ID: 22993318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanoparticles as photosensitizer delivery carriers for enhanced photodynamic cancer therapy.
    Zhang Y; Wang B; Zhao R; Zhang Q; Kong X
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111099. PubMed ID: 32600703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.